FDA push for cheaper 'biosimilar' drugs could challenge pharma's biggest blockbusters

FDA push for cheaper 'biosimilar' drugs could challenge pharma's biggest blockbusters  MarketWatch The FDA Considers Regulating Over-The-Counter E-Cig Sales  Vaping Post (blog) FDA lays out strategy to improve US diet  Agri-PulseFull coverage

(CLICK HERE TO READ AND SEE MORE)